Abiopharma

New Form 8-K - AbbVie Inc. Filed: 2025-07-03 AccNo: 0001551152-25-000034 Size: 263 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 144 - Viking Therapeutics, Inc. Filed: 2025-07-03 AccNo: 0001950047-25-004829 Size: 4 KB

New Form 4 - VOLITIONRX LTD Filed: 2025-07-03 AccNo: 0001477932-25-004916 Size: 6 KB

New Form 4 - VOLITIONRX LTD Filed: 2025-07-03 AccNo: 0001477932-25-004917 Size: 5 KB

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - VOLITIONRX LTD Filed: 2025-07-03 AccNo: 0001477932-25-004915 Size: 7 KB

New Form 4 - VOLITIONRX LTD Filed: 2025-07-03 AccNo: 0001477932-25-004914 Size: 5 KB

New Form 4 - VOLITIONRX LTD Filed: 2025-07-03 AccNo: 0001477932-25-004913 Size: 5 KB

New Form 4 - VOLITIONRX LTD Filed: 2025-07-03 AccNo: 0001477932-25-004912 Size: 5 KB

New Form 144 - Viking Therapeutics, Inc. Filed: 2025-07-03 AccNo: 0001950047-25-004828 Size: 4 KB

New Form 144 - Viking Therapeutics, Inc. Filed: 2025-07-03 AccNo: 0001950047-25-004825 Size: 4 KB

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit